Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 17:03 ET | Source: Future Money Acquisition Corporation

Future Money Acquisition Corporation Announces Pricing of $100,000,000 Initial Public Offering

New York, NY, March 26, 2026 (GLOBE NEWSWIRE) -- Future Money Acquisition Corporation (NASDAQ: FMACU) (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units...
March 26, 2026 16:35 ET | Source: Blue Jay Gold Corp

Blue Jay Gold Corp. Announces the Passing of Director, Marcio Fonseca

VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Blue Jay Gold Corp. (“Blue Jay” or the “Company”), is deeply saddened to announce the sudden and unexpected passing of Marcio Fonseca,...
March 26, 2026 16:32 ET | Source: XORTX Therapeutics Inc.

XORTX Announces Change of Effective Date of Share Consolidation

CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...
March 26, 2026 16:30 ET | Source: CVB Financial Corp

Proposed Merger Approved by Shareholders of CVB Financial Corp. and Shareholders of Heritage Commerce Corp.

ONTARIO, Calif. and SAN JOSE, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ: CVBF), the holding company for Citizens Business Bank, and Heritage Commerce Corp (NASDAQ:...
March 26, 2026 16:16 ET | Source: Vivani Medical, Inc.

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-acting semaglutide implant under...
March 26, 2026 16:10 ET | Source: Xos, Inc.

Xos Delivers Third Consecutive Quarter of Positive Operating and Free Cash Flow, Accelerates Platform Expansion Across Vehicles, Powertrains, and Energy Storage

Xos Delivers Third Consecutive Quarter of Positive Operating and Free Cash Flow, Accelerates Platform Expansion Across Three Product Lines?
March 26, 2026 16:05 ET | Source: Spero Therapeutics, Inc.

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

Spero announced the resubmission of tebipenem HBr New Drug Application (NDA) to the FDA for complicated urinary tract infections (cUTI), including pyelonephritis in December 2025In February, Spero’s...
March 26, 2026 16:05 ET | Source: LB Pharmaceuticals Inc

LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Reported positive results from potentially registrational Phase 2 trial ofLB-102 in schizophrenia Advanced LB-102 into late-stage development in multiple indications with initiation ofa pivotal Phase...
March 26, 2026 16:05 ET | Source: SKYX Platforms Corp.

SKYX Reports Another Record Quarter with Revenue of $25 Million in Q-4 Demonstrating 8 Consecutive Quarters of Year Over Year Growth with Annual Record Revenue of $92 Million in 2025 Compared to $86 Million in 2024 as it Continues to Grow its Market Penetration

SKYX Reports Another Record Quarter with Revenue of $25 Million in Q-4, Demonstrating 8 Consecutive Quarters of Year Over Year Growth
March 26, 2026 16:05 ET | Source: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates

On track for DENALI Part 2a dose confirmation in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalOn track to initiate the ASPENOVA Phase...